TGFB1 and pancreatic neoplasm: TGF-β1 contained in pancreatic cancer-derived EVs suppresses NK cell cytotoxic activity against tumor cells via SMAD2/3-dependent signal pathway, resulting in immune tolerance and tumor immunosuppression (167).